What are the management steps for postpartum hemorrhage (PPH) based on the 4 Ts: tone, tissue, trauma, and thrombin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Postpartum Hemorrhage Using the 4 Ts Framework

Postpartum hemorrhage should be managed systematically using the 4 Ts mnemonic (Tone, Tissue, Trauma, Thrombin), with immediate administration of tranexamic acid 1 g IV over 10 minutes as the critical first-line intervention alongside uterotonic therapy, as effectiveness declines by 10% for every 15 minutes of delay. 1

Initial Resuscitation and Immediate Interventions

  • Administer tranexamic acid (TXA) 1 g IV over 10 minutes immediately upon recognition of PPH, as it reduces bleeding-related mortality when given within 3 hours of delivery and decreases the need for laparotomy 1
  • Begin uterine massage to stimulate contractions while simultaneously assessing the cause 2
  • Establish IV access and initiate crystalloid resuscitation to maintain hemodynamic stability 3
  • Monitor vital signs continuously, including heart rate, blood pressure, and oxygen saturation 3
  • Administer supplemental oxygen in cases of severe PPH 4

The 4 Ts: Systematic Cause Identification and Treatment

1. TONE (Uterine Atony) - Most Common Cause (>75% of cases)

Clinical diagnosis: Soft, boggy uterus on palpation 3, 2

Management sequence:

  • Bimanual uterine massage as first mechanical intervention 2
  • Oxytocin 10 IU IM or slow IV push (over 1-2 minutes), followed by continuous infusion of 20-40 IU in 1000 mL at 150 mL/hour, not exceeding 40 IU cumulative dose 5, 4
  • If oxytocin fails within 30 minutes, administer sulprostone as second-line agent 4
  • Carboprost tromethamine 250 mcg IM can be used for refractory atony after oxytocin failure 6
  • Methylergonovine 0.2 mg IM is an alternative but is absolutely contraindicated in hypertensive patients due to severe vasoconstriction risk 2, 7
  • Intrauterine balloon tamponade should be attempted if pharmacologic measures fail before proceeding to surgery or interventional radiology 4

Surgical options for refractory atony:

  • Bilateral uterine artery ligation 2
  • B-Lynch compression sutures 2
  • Hysterectomy as last resort 2

2. TISSUE (Retained Placental Tissue)

Clinical diagnosis: Incomplete placental delivery or retained fragments 8

Management:

  • Manual uterine examination with antibiotic prophylaxis to identify and remove retained tissue 4
  • Ultrasound can assist in identifying retained products of conception, though this is more common in delayed PPH 3
  • Consider intraumbilical injection of oxytocin (10-30 IU) or misoprostol (800 mcg) before manual removal if placenta is adherent 9

3. TRAUMA (Lacerations, Hematomas, Uterine Rupture)

Clinical diagnosis: Continued bleeding despite firm, contracted uterus 8

Management:

  • Thorough visual inspection of the cervix, vagina, and perineum to identify lacerations 2
  • Immediate surgical repair of identified lacerations with appropriate suturing 8
  • CT with IV contrast in hemodynamically stable patients to localize bleeding source and identify hematomas or uterine rupture 3
  • Pelvic packing can be highly effective for stabilization in cases of severe intractable pelvic hemorrhage, left in place for 24 hours with open abdomen and ventilatory support 3

4. THROMBIN (Coagulopathy)

Clinical diagnosis: Diffuse oozing from multiple sites, failure to form clots 8

Laboratory assessment:

  • Obtain baseline platelet count, PT, PTT, and fibrinogen levels immediately 3
  • Fibrinogen <2 g/L occurs in 17% of cases with blood loss >2000 mL and is an early predictor of severe PPH 1
  • Point-of-care testing with thromboelastography/thromboelastometry provides rapid results (FIBTEM values decline faster than standard fibrinogen levels) 3, 10

Management:

  • Do not wait for laboratory results before transfusing in active hemorrhage 3, 4
  • Maintain fibrinogen ≥2 g/L with cryoprecipitate or fibrinogen concentrate 1, 4
  • Transfuse packed RBCs, fresh frozen plasma, and platelets in 1:1:1 ratio during massive hemorrhage 2, 11
  • Target hemoglobin >8 g/dL 4
  • Platelet transfusion is rarely needed unless blood loss exceeds 5000 mL or platelet count <75 × 10⁹/L 1

Critical Supportive Measures

  • Prevent hypothermia by warming all infusion solutions and blood products and using active skin warming, as clotting factors function poorly below 36°C 3, 4
  • Avoid and correct acidosis, which impairs coagulation 3
  • Maintain lateral decubitus positioning to optimize hemodynamics 3
  • Re-dose prophylactic antibiotics if blood loss exceeds 1500 mL 3

Advanced Interventions for Refractory Hemorrhage

Interventional radiology:

  • Uterine artery embolization should be considered in hemodynamically stable patients who have failed medical management and non-surgical interventions 3, 1
  • Transfer for embolization is possible only after ruling out hemoperitoneum and confirming hemodynamic stability 4

Surgical interventions:

  • Hypogastric artery ligation may be attempted by experienced surgeons, though efficacy is limited by collateral circulation 3
  • Damage control surgery principles apply in cases of deep hemorrhagic shock with ongoing bleeding and coagulopathy 3

Common Pitfalls to Avoid

  • Never use methylergonovine in hypertensive patients - risk of severe hypertension and stroke 2, 7
  • Avoid hypotonic solutions like Ringer's lactate in patients requiring massive resuscitation 3
  • Do not delay TXA administration - effectiveness decreases 10% every 15 minutes 1
  • Do not perform rapid IV bolus of oxytocin >10 IU - risk of hypotension and cardiovascular collapse 5
  • Do not rely on visual estimation of blood loss - use clinical markers (vital signs, symptoms) and collection bags for accurate assessment 4, 9
  • Recognize that prostaglandin F analogues should be avoided when increased pulmonary artery pressure is undesirable 3

References

Guideline

Management of Postpartum Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Postpartum Uterine Atony

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Postpartum Hemorrhage: Prevention and Treatment.

American family physician, 2017

Research

Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.